Ignite Creation Date:
2025-12-25 @ 5:11 AM
Ignite Modification Date:
2026-02-25 @ 5:51 PM
Study NCT ID:
NCT00740727
Status:
COMPLETED
Last Update Posted:
2009-09-11
First Post:
2008-08-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
EASI Access II --- Follow-up Study to the EASI Access Trial
Sponsor:
Massachusetts General Hospital
Organization:
Study Overview
Official Title:
Enzymatically Augmented Subcutaneous Infusion (EASI) Access II Trial
Status:
COMPLETED
Status Verified Date:
2009-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Test whether Basic Life Support (BLS) providers can successfully place Enzymatically Augmented Subcutaneous Infusion (EASI) Access lines for subcutaneous infusion, and characterize intravascular absorption of EASI-administered (tracer-labelled) glucose (D5W).
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: